fluocinonide has been researched along with Candidiasis, Oral in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berg, KM; Bowers, LM; Brennan, MT; DeRossi, SS; Marable, DR; Sankar, V; Stewart, CM; Stout, TL; Thoppay, JR | 1 |
Carré, B; Coulombe, C; Deslauriers, N; Goulet, JP | 1 |
2 other study(ies) available for fluocinonide and Candidiasis, Oral
Article | Year |
---|---|
Oral candidiasis following steroid therapy for oral lichen planus.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Betamethasone; Candidiasis, Oral; Clotrimazole; Dexamethasone; Drug Combinations; Drug Therapy, Combination; Female; Fluocinonide; Glucocorticoids; Humans; Incidence; Lichen Planus, Oral; Male; Middle Aged; Retrospective Studies; Young Adult | 2016 |
Topical application of a corticosteroid destabilizes the host-parasite relationship in an experimental model of the oral carrier state of Candida albicans.
Topics: Administration, Topical; Animals; Candidiasis, Oral; Carrier State; CD4-Positive T-Lymphocytes; Dose-Response Relationship, Drug; Fluocinonide; Host-Parasite Interactions; Hypersensitivity, Delayed; Lymph Nodes; Lymphocyte Activation; Macrophage-1 Antigen; Male; Mice; Mice, Inbred DBA; Mouth Mucosa; Spleen; T-Lymphocyte Subsets | 1995 |